Qizhiweitong granule alleviates diarrhea-predominant irritable bowel syndrome via inhibition of the IL-6/Src/STAT3 feedback loop
Dados Bibliográficos
| ID | 14744909 |
|---|---|
| Autores | Qing Ma (0000-0003-3125-3513, Guangzhou University of Chinese Medicine), Zhangyu Jiang (0000-0002-0648-2800, Guangzhou University of Chinese Medicine), Zerong Zhang (Guangzhou University of Chinese Medicine), Lizhu Sun, Liqi Sun (0000-0003-1832-2959, Guangzhou University of Chinese Medicine), Tao Su (0000-0002-9148-6127, Guangzhou University of Chinese Medicine), Zhongqiu Liu (0000-0001-6986-9677, Guangzhou University of Chinese Medicine, autor correspondente), Rong Zhang (0000-0003-1124-3668, Guangzhou University of Chinese Medicine, autor correspondente) |
| Ano | 2026 |
| Volume | 356 |
| Páginas | 120772 |
| Data de publicação | 2026-02-01 |
| Peer Reviewed | Sim |
| Open Access | Sim |
| Tipo | ARTICLE |
| Periódico | Journal of Ethnopharmacology (JOURNAL) |
| Identificadores do periódico | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Editora | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2025.120772 |
| PMID | 41135620 |
| OpenAlex | W4415459680 |
| Idioma | EN |
| Referências citadas | 25 |
Feedback Control · Feedback loop · Feedback regulation · Granule (geology · Inflammation · Irritable bowel syndrome · Pathophysiology · Gastrointestinal motility and disorders · Gut microbiota and health · Helicobacter pylori-related gastroenterology studies · Pharmacological Effects of Natural Compounds
Co-existing polysaccharides affect the systemic exposure of major bioactive ingredients in Chang-Kang-Fang, a multi-herb prescription for treatment of irritable bowel syndrome
Laxative activities of Cassia sieberiana and Senna obtusifolia
Anti-inflammatory and immunomodulatory effects of Glycyrrhiza uralensis fisch. On ulcerative colitis in rats
Glycyrrhizic acid reduces neutrophil extracellular trap formation to ameliorate colitis-associated colorectal cancer by inhibiting peptidylarginine deiminase 4
Chang-Kang-Fang alleviates diarrhea predominant irritable bowel syndrome (IBS-D) through inhibiting TLR4/NF-κB/NLRP3 pathway
| Velocidade de citação | historical |
|---|---|
| Altamente citado | Não |